Issue 18, 2021

Mid-infrared spectral classification of endometrial cancer compared to benign controls in serum or plasma samples

Abstract

This study demonstrates a discrimination of endometrial cancer versus (non-cancerous) benign controls based on mid-infrared (MIR) spectroscopy of dried plasma or serum liquid samples. A detailed evaluation was performed using four discriminant methods (LDA, QDA, kNN or SVM) to execute the classification task. The discriminant methods used in the study comprised methods that are widely used in the statistics (LDA and QDA) and machine learning literature (kNN and SVM). Of particular interest, is the impact of discrimination when presented with spectral data from a section of the bio-fingerprint region (1430 cm−1 to 900 cm−1) in contrast to the more extended bio-fingerprint region used here (1800 cm−1 to 900 cm−1). Quality metrics used were the misclassification rate, sensitivity, specificity, and Matthew's correlation coefficient (MCC). For plasma (with spectral data ranging from 1430 cm−1 to 900 cm−1), the best performing classifier was kNN, which achieved a sensitivity, specificity and MCC of 0.865 ± 0.043, 0.865 ± 0.023 and 0.762 ± 0.034, respectively. For serum (in the same wavenumber range), the best performing classifier was LDA, achieving a sensitivity, specificity and MCC of 0.899 ± 0.023, 0.763 ± 0.048 and 0.664 ± 0.067, respectively. For plasma (with spectral data ranging from 1800 cm−1 to 900 cm−1), the best performing classifier was SVM, with a sensitivity, specificity and MCC of 0.993 ± 0.010, 0.815 ± 0.000 and 0.815 ± 0.010, respectively. For serum (in the same wavenumber range), QDA performed best achieving a sensitivity, specificity and MCC of 0.852 ± 0.023, 0.700 ± 0.162 and 0.557 ± 0.012, respectively. Our findings demonstrate that even when a section of the bio-fingerprint region has been removed, good classification of endometrial cancer versus non-cancerous controls is still maintained. These findings suggest the potential of a MIR screening tool for endometrial cancer screening.

Graphical abstract: Mid-infrared spectral classification of endometrial cancer compared to benign controls in serum or plasma samples

Supplementary files

Article information

Article type
Paper
Submitted
09 May 2021
Accepted
27 Jul 2021
First published
29 Jul 2021
This article is Open Access
Creative Commons BY license

Analyst, 2021,146, 5631-5642

Mid-infrared spectral classification of endometrial cancer compared to benign controls in serum or plasma samples

D. Mabwa, K. Gajjar, D. Furniss, R. Schiemer, R. Crane, C. Fallaize, P. L. Martin-Hirsch, F. L. Martin, T. Kypraios, A. B. Seddon and S. Phang, Analyst, 2021, 146, 5631 DOI: 10.1039/D1AN00833A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements